title: [Aromatase inhibitors--new applications in gynecology].
abstract: P-450 aromatase inhibitors, designed for suppressing estradiol production, were first approved for the treatment of advanced breast cancer. Recent studies have provided evidence that aromatase inhibitors may be effective in the short term for induction of ovulation and in the long-term for treatment of endometriosis. Based on current data, the role of aromatase inhibitors in the management of various gynecological conditions may soon be widely determined.
authors.affiliation: IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Shrim
authors.forename: S E
authors.initials: SE
authors.lastname: Elizur
authors.forename: M E
authors.initials: ME
authors.lastname: Beiner
authors.forename: A
authors.initials: A
authors.lastname: Wiser
authors.forename: D S
authors.initials: DS
authors.lastname: Seidman
mesh_terms: D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D010062:Ovulation Induction
chemical_list: D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists